Natural History of Metameric Spinal Cord Arteriovenous Malformations.

IF 8.9 1区 医学 Q1 CLINICAL NEUROLOGY
Bikei Ryu, Arturo Consoli, Alessandro Sgreccia, Silvia Pizzuto, Stanislas Smajda, Federico Di Maria, Georges Rodesch
{"title":"Natural History of Metameric Spinal Cord Arteriovenous Malformations.","authors":"Bikei Ryu, Arturo Consoli, Alessandro Sgreccia, Silvia Pizzuto, Stanislas Smajda, Federico Di Maria, Georges Rodesch","doi":"10.1161/STROKEAHA.125.051848","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Spinal arteriovenous metameric syndrome (SAMS) is a rare form of spinal cord arteriovenous malformations with a metameric distribution affecting the spinal cord and related structures derived from the same embryological segment. Its natural history and impact on clinical outcomes, compared with nonmetameric spinal cord arteriovenous malformations, remain unclear.</p><p><strong>Methods: </strong>This retrospective, single-center study included 253 patients with intradural spinal cord arteriovenous malformations between 2002 and 2024, that have either not been considered for embolization or followed up during the period before embolization. This study aimed to evaluate the natural history of SAMS and identify the risk factors for clinical worsening, hemorrhagic events, and angiographic worsening during observation. A stratified log-rank test and Cox proportional hazards model were used to estimate hazard ratios (HRs) and 95% CI.</p><p><strong>Results: </strong>In the overall population, the median age of onset was 24 years, females accounted for 130 patients (51.3%), and the median observational period was 19 months. This cohort included 71 patients with SAMS and 182 without SAMS. The 10-year cumulative rates of clinical worsening were 27.0% in the metameric and 18.0% in the nonmetameric group. The risk of clinical worsening and hemorrhagic events did not show statistically significant differences between the 2 groups (HR, 1.71 [95% CI, 0.83-3.54]; <i>P</i>=0.137 and HR, 1.65 [95% CI, 0.75-3.61]; <i>P</i>=0.199). The metameric group with hemorrhagic onset had the highest risk of experiencing hemorrhagic events compared with the nonmetameric group without hemorrhagic onset (HR, 4.87 [95% CI, 1.35-17.53]; <i>P</i>=0.015). The metameric group exhibited significantly higher rates of angiographic worsening compared with the nonmetameric group (HR, 11.37 [95% CI, 1.32-97.78]; <i>P</i>=0.005). The presence of nonspinal cord-associated metameric lesions did not significantly affect the natural history of SAMS.</p><p><strong>Conclusions: </strong>SAMS had higher angiographic worsening than non-SAMS. Hemorrhagic onset in SAMS was an independent predictor of rebleeding during observation, without any influence of nonspinal cord-associated metameric lesions. Close radiological follow-up and early intervention, particularly for hemorrhagic-onset cases, may be necessary to improve outcomes.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":8.9000,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/STROKEAHA.125.051848","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Spinal arteriovenous metameric syndrome (SAMS) is a rare form of spinal cord arteriovenous malformations with a metameric distribution affecting the spinal cord and related structures derived from the same embryological segment. Its natural history and impact on clinical outcomes, compared with nonmetameric spinal cord arteriovenous malformations, remain unclear.

Methods: This retrospective, single-center study included 253 patients with intradural spinal cord arteriovenous malformations between 2002 and 2024, that have either not been considered for embolization or followed up during the period before embolization. This study aimed to evaluate the natural history of SAMS and identify the risk factors for clinical worsening, hemorrhagic events, and angiographic worsening during observation. A stratified log-rank test and Cox proportional hazards model were used to estimate hazard ratios (HRs) and 95% CI.

Results: In the overall population, the median age of onset was 24 years, females accounted for 130 patients (51.3%), and the median observational period was 19 months. This cohort included 71 patients with SAMS and 182 without SAMS. The 10-year cumulative rates of clinical worsening were 27.0% in the metameric and 18.0% in the nonmetameric group. The risk of clinical worsening and hemorrhagic events did not show statistically significant differences between the 2 groups (HR, 1.71 [95% CI, 0.83-3.54]; P=0.137 and HR, 1.65 [95% CI, 0.75-3.61]; P=0.199). The metameric group with hemorrhagic onset had the highest risk of experiencing hemorrhagic events compared with the nonmetameric group without hemorrhagic onset (HR, 4.87 [95% CI, 1.35-17.53]; P=0.015). The metameric group exhibited significantly higher rates of angiographic worsening compared with the nonmetameric group (HR, 11.37 [95% CI, 1.32-97.78]; P=0.005). The presence of nonspinal cord-associated metameric lesions did not significantly affect the natural history of SAMS.

Conclusions: SAMS had higher angiographic worsening than non-SAMS. Hemorrhagic onset in SAMS was an independent predictor of rebleeding during observation, without any influence of nonspinal cord-associated metameric lesions. Close radiological follow-up and early intervention, particularly for hemorrhagic-onset cases, may be necessary to improve outcomes.

异长性脊髓动静脉畸形的自然史。
背景:脊髓动静脉异长综合征(SAMS)是一种罕见的脊髓动静脉畸形,其异长分布影响脊髓及来自同一胚胎节段的相关结构。与非异位性脊髓动静脉畸形相比,其自然史和对临床结果的影响尚不清楚。方法:本回顾性单中心研究纳入了2002 - 2024年间253例硬膜内脊髓动静脉畸形患者,这些患者要么未考虑栓塞,要么在栓塞前随访。本研究旨在评估SAMS的自然病史,并在观察期间确定临床恶化、出血事件和血管造影恶化的危险因素。采用分层对数秩检验和Cox比例风险模型估计风险比(hr)和95% CI。结果:总体人群中,发病年龄中位数为24岁,女性130例(51.3%),中位观察期为19个月。该队列包括71例SAMS患者和182例非SAMS患者。10年累积临床恶化率,异聚体组为27.0%,非异聚体组为18.0%。两组患者临床恶化和出血性事件的风险差异无统计学意义(HR, 1.71 [95% CI, 0.83-3.54]; P=0.137; HR, 1.65 [95% CI, 0.75-3.61]; P=0.199)。与无出血发作的非异聚体组相比,有出血发作的异聚体组发生出血事件的风险最高(HR, 4.87 [95% CI, 1.35-17.53]; P=0.015)。异谱组血管造影恶化率明显高于非异谱组(HR, 11.37 [95% CI, 1.32-97.78]; P=0.005)。非脊髓相关异聚性病变的存在对SAMS的自然史没有显著影响。结论:SAMS血管造影恶化程度高于非SAMS血管造影。在观察期间,SAMS的出血发作是再出血的独立预测因素,没有任何非脊髓相关的特异功能病变的影响。密切的放射随访和早期干预,特别是对出血性病例,可能是改善预后的必要条件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Stroke
Stroke 医学-临床神经学
CiteScore
13.40
自引率
6.00%
发文量
2021
审稿时长
3 months
期刊介绍: Stroke is a monthly publication that collates reports of clinical and basic investigation of any aspect of the cerebral circulation and its diseases. The publication covers a wide range of disciplines including anesthesiology, critical care medicine, epidemiology, internal medicine, neurology, neuro-ophthalmology, neuropathology, neuropsychology, neurosurgery, nuclear medicine, nursing, radiology, rehabilitation, speech pathology, vascular physiology, and vascular surgery. The audience of Stroke includes neurologists, basic scientists, cardiologists, vascular surgeons, internists, interventionalists, neurosurgeons, nurses, and physiatrists. Stroke is indexed in Biological Abstracts, BIOSIS, CAB Abstracts, Chemical Abstracts, CINAHL, Current Contents, Embase, MEDLINE, and Science Citation Index Expanded.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信